Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lupus Erythematosus, Systemic × High-Intensity Interval Training × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 2 Cardiotoxicity 2 Primary Dysautonomias 1 Pediatric Brain Tumor 1 Ovarian Neoplasms 1 Neoplasms 1 Lupus Erythematosus, Systemic 1 Lung Neoplasms 1 Hodgkin Disease 1 Esophageal Neoplasms 1 Cardiovascular Diseases 1 Breast Neoplasms 1 Brain Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

sotrovimab 1 ciclesonide 1 anifrolumab 1 Standard of Care 1 Specimen Handling 1 Practice Guidelines as Topic 1 Nivolumab 1 Niclosamide 1 Methods 1 Interviews as Topic 1 Immune Checkpoint Inhibitors 1 High-Intensity Interval Training 1 Exercise 1 Educational Status 1 Early Intervention, Educational 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05478018 2025-09-09

LUPEX

Rigshospitalet, Denmark

Phase NA Completed

Lupus Erythematosus, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡